A Phase I Dose-Escalation Study of The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Polyethylene Glycol-Erythropoietin (PEG-EPO) in Healthy Subjects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Phase I Dose-Escalation Study of The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Polyethylene Glycol-Erythropoietin (PEG-EPO) in Healthy Subjects

Published:2024-08 Issue:8 Volume:46 Page:636-643
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Hu Chaoying,Sun Wanling,Wu Yuanyuan,Huang Junlong,Zhang Xiangrong,Zhang Lan

Publisher

Elsevier BV

Reference27 articles.

1. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990-2021: findings from the Global Burden of Disease Study 2021;Lancet Haematol.,2023

2. An update on the global disparities in kidney disease burden and care across world countries and regions;Bello;Lancet Glob Health,2024

3. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017;Lancet,2020

4. Chronic kidney disease diagnosis and management: a review;Chen;JAMA,2019

5. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy;Thurlow;Am J Nephrol,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP